Tenax Therapeutics Inc — Quarterly Financial Statistics (NASDAQ:TENX)

Financials

Cash from operating activities -3.09 M-3.53 M-6.97 M-6.26 M-9.15 M -25.91 M Cash from investing activities 00000 0 Cash from financing activities 92.01 M67 K23.56 M278 K3.06 M 26.97 M Free cash flow -3.09 M-3.53 M-6.97 M-6.26 M-9.15 M -25.91 M

뉴스

Tenax Therapeutics: Some Future Potential (NASDAQ:TENX)

Tenax Therapeutics Stock: A Speculative Buy (NASDAQ:TENX)

Tenax: Lower Variance In Phase 3 Has "Loaded The Dice" For An Asymmetric Repricing

Tesla, Goldman Sachs among market cap stock movers on Monday

테낙스 테라퓨틱스, 3상 LEVEL 연구 등록 목표 확인

Tenax Therapeutics’ phase 3 LEVEL study confirms enrollment target

Tenax Therapeutics 목표 주가, Guggenheim, 14달러에서 25달러로 상향

Tenax Therapeutics stock price target raised to $25 from $14 at Guggenheim

테낙스 테라퓨틱스 이사 Rich Stuart, 50,792달러 상당의 주식 매입

Tenax Therapeutics director Rich Stuart buys $50,792 in stock

Giordano buys Tenax Therapeutics (TENX) shares worth $19,999

Tenax Therapeutics 임시 CFO, 58,164달러 상당 주식 매입